This study will test the effectiveness, implementation outcomes, and cost effectiveness of a community-tailored, harm reduction kiosk in reducing HIV, hepatitis C, and overdose risk behavior in rural Appalachia. The proposed project will take place in two counties in Appalachian Kentucky, an epicenter for the intertwined national crises of injection drug use, overdoses, and hepatitis C.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Change in syringe coverage for injections
Timeframe: Measured at baseline and then every 6 months up to 5 years
Change in harm reduction program supplied syringe coverage for injections
Timeframe: Measured at baseline and then every 6 months up to 5 years
Change in SSP / KyOSK-provided syringe coverage for injections
Timeframe: Measured at baseline and then every 6 months up to 5 years